[Antilipemic activity of epomediol in patients with primary hyperlipidemia].
Saba
P
P
Galeone
F
F
Natali
A
A
Scalabrino
A
A
Giuntoli
F
F
Brunelleschi
G
G
D000368:Aged; D019086:Bridged Bicyclo Compounds, Heterocyclic; D002756:Cholagogues and Choleretics / Q000008:administration & dosage / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013729:Terpenes / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D019086:Bridged Bicyclo Compounds, Heterocyclic; D002756:Cholagogues and Choleretics; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D013729:Terpenes; D014280:Triglycerides; D002784:Cholesterol; C031365:epomediol
Attività ipolipidemizzante dell'epomediol in pazienti con iperlipidemia primitiva.